Logo image of CRCL

CIRCLE INTERNET GROUP INC (CRCL) Stock Fundamental Analysis

NYSE:CRCL - New York Stock Exchange, Inc. - US1725731079 - Common Stock - Currency: USD

168.1  -15.42 (-8.4%)

After market: 167.59 -0.51 (-0.3%)

Fundamental Rating

2

Taking everything into account, CRCL scores 2 out of 10 in our fundamental rating. CRCL was compared to 0 industry peers in the Unkown industry. CRCL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CRCL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CRCL had positive earnings in the past year.
In the past year CRCL had a positive cash flow from operations.
CRCL Yearly Net Income VS EBIT VS OCF VS FCFCRCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 0.25%
ROE 8.26%
ROIC 6.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRCL Yearly ROA, ROE, ROICCRCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10 15

1.3 Margins

Industry RankSector Rank
OM 10.11%
PM (TTM) 9.29%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRCL Yearly Profit, Operating, Gross MarginsCRCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -20 -40 -60 -80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRCL is destroying value.
The number of shares outstanding for CRCL remains at a similar level compared to 1 year ago.
The debt/assets ratio for CRCL has been reduced compared to a year ago.
CRCL Yearly Shares OutstandingCRCL Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 50M 100M 150M 200M
CRCL Yearly Total Debt VS Total AssetsCRCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 10B 20B 30B 40B

2.2 Solvency

Based on the Altman-Z score of 0.44, we must say that CRCL is in the distress zone and has some risk of bankruptcy.
CRCL has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
CRCL has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Although CRCL does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.14
Altman-Z 0.44
ROIC/WACC0.67
WACC10.02%
CRCL Yearly LT Debt VS Equity VS FCFCRCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CRCL has a Current Ratio of 1.02. This is a normal value and indicates that CRCL is financially healthy and should not expect problems in meeting its short term obligations.
CRCL has a Quick Ratio of 1.02. This is a normal value and indicates that CRCL is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
CRCL Yearly Current Assets VS Current LiabilitesCRCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

The earnings per share for CRCL have decreased strongly by -41.80% in the last year.
Looking at the last year, CRCL shows a quite strong growth in Revenue. The Revenue has grown by 15.57% in the last year.
EPS 1Y (TTM)-41.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.82%
Revenue 1Y (TTM)15.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%58.47%

3.2 Future

CRCL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.32% yearly.
The Revenue is expected to grow by 31.38% on average over the next years. This is a very strong growth
EPS Next Y-137.35%
EPS Next 2Y19.63%
EPS Next 3Y51.32%
EPS Next 5YN/A
Revenue Next Year41.03%
Revenue Next 2Y28.36%
Revenue Next 3Y31.38%
Revenue Next 5YN/A

3.3 Evolution

CRCL Yearly Revenue VS EstimatesCRCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 1B 2B 3B
CRCL Yearly EPS VS EstimatesCRCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 236.76, CRCL can be considered very expensive at the moment.
CRCL is valuated expensively when we compare the Price/Earnings ratio to 26.82, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 165.42, the valuation of CRCL can be described as expensive.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, CRCL is valued quite expensively.
Industry RankSector Rank
PE 236.76
Fwd PE 165.42
CRCL Price Earnings VS Forward Price EarningsCRCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF 144.92
EV/EBITDA -91.61
CRCL Per share dataCRCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

CRCL's earnings are expected to grow with 51.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.63%
EPS Next 3Y51.32%

0

5. Dividend

5.1 Amount

No dividends for CRCL!.
Industry RankSector Rank
Dividend Yield N/A

CIRCLE INTERNET GROUP INC

NYSE:CRCL (8/1/2025, 8:04:01 PM)

After market: 167.59 -0.51 (-0.3%)

168.1

-15.42 (-8.4%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)08-12 2025-08-12
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner Change-69.1%
Market Cap37.41B
Analysts76
Price Target209.99 (24.92%)
Short Float %2.72%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 236.76
Fwd PE 165.42
P/S 22.32
P/FCF 144.92
P/OCF 115.54
P/B 19.84
P/tB 29.12
EV/EBITDA -91.61
EPS(TTM)0.71
EY0.42%
EPS(NY)1.02
Fwd EY0.6%
FCF(TTM)1.16
FCFY0.69%
OCF(TTM)1.45
OCFY0.87%
SpS7.53
BVpS8.47
TBVpS5.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.25%
ROE 8.26%
ROCE 8.59%
ROIC 6.7%
ROICexc N/A
ROICexgc N/A
OM 10.11%
PM (TTM) 9.29%
GM N/A
FCFM 15.4%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.14
Debt/EBITDA 0.17
Cap/Depr 123.51%
Cap/Sales 3.92%
Interest Coverage 941.44
Cash Conversion 145.45%
Profit Quality 165.83%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 0.44
F-ScoreN/A
WACC10.02%
ROIC/WACC0.67
Cap/Depr(3y)123.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.83%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.82%
EPS Next Y-137.35%
EPS Next 2Y19.63%
EPS Next 3Y51.32%
EPS Next 5YN/A
Revenue 1Y (TTM)15.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%58.47%
Revenue Next Year41.03%
Revenue Next 2Y28.36%
Revenue Next 3Y31.38%
Revenue Next 5YN/A
EBIT growth 1Y-30.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y171.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.18%
OCF growth 3YN/A
OCF growth 5YN/A